Bausch Health Companies Inc
NYSE:BHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bausch Health Companies Inc
NYSE:BHC
|
CA |
|
Avcorp Industries Inc
TSX:AVP
|
CA |
|
GSH Corporation Ltd
SGX:BDX
|
SG |
|
Sekisui House Ltd
F:SPH1
|
JP |
|
Shimano Inc
F:SHM
|
JP |
|
BHP Group Ltd
ASX:BHP
|
AU |
|
D
|
Deere & Co
XMUN:DCO
|
US |
|
I
|
Ideanomics Inc
F:0V5
|
US |
Wall St Price Targets
BHC Price Targets Summary
Bausch Health Companies Inc
According to Wall Street analysts, the average 1-year price target for
BHC is 6.46 USD with a low forecast of 6.4 USD and a high forecast of 6.65 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BHC's stock price target?
Price Target
6.46
USD
According to Wall Street analysts, the average 1-year price target for
BHC is 6.46 USD with a low forecast of 6.4 USD and a high forecast of 6.65 USD.
What is the Revenue forecast for Bausch Health Companies Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 7 years is 0%.
What is the Gross Profit forecast for Bausch Health Companies Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 7 years is -2%.
What is the Operating Income forecast for Bausch Health Companies Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 7 years is 5%.
What is the Pre-Tax Income forecast for Bausch Health Companies Inc?
Projected CAGR
61%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 61%.
What is the Net Income forecast for Bausch Health Companies Inc?
Projected CAGR
38%
The compound annual growth rate for Net Income over the next 7 years is 38%.